GeneNews Inks Specimen Collection Service Deal for ColonSentry | GenomeWeb

NEW YORK (GenomeWeb News) — GeneNews said today that it has signed up a lab services provider to expand its colon cancer risk test in Southwestern Ontario.

Gamma-Dynacare Medical Laboratories will provide blood specimen collection services for the ColonSentry test from three of its patient service centers in London, Ontario. The company estimated that the agreement has potentially made its test available to the nearly 500,000 people in this region of Ontario who are between 50 and 79 years old.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.